Machine Learning

Lockton and Nexar's new AV safety standard uses real-world data to finally answer the question: Are autonomous cars safer than us? The answer could unlock billions.

Despite massive security investments, known vulnerabilities are wreaking havoc. A new report reveals why AI demands a shift from pre-production to runtime defense.

As AI-powered cyberattacks escalate, one company is fighting fire with fire. Skyhawk Security's award-winning AI Red Team is a game-changer.

With dual FDA clearances secured, Rhythm AI appoints serial acquirer Mike Dineen as CEO, signaling a strategic pivot from innovation to market conquest.

A new study reveals molecular and AI-imaging tests provide distinct clues for Parkinson's, championing a dual-biomarker approach for earlier, more accurate diagnosis.

A major investment in SewerAI signals a tech-driven shift in tackling the nation's hidden infrastructure decay, as AI platforms replace guesswork with data.

A new private equity firm defies the odds, closing an oversubscribed fund by focusing on mission-critical software and AI. What does this signal for tech investing?

Chandigarh University and Intel launch a new AI lab, a strategic move in a larger national plan to close the tech skill gap and build an AI-ready workforce.

Elly launches AI Sourcer to replace the chaotic patchwork of hiring tools with a single, conversational AI platform. But can it cure the chronic fragmentation of HR tech?

Redpoint Advisors' acquisition of VoxCroft Analytics integrates advanced AI to decode complex regions, signaling a new era for technology-driven risk management.

A landmark collaboration between Wolters Kluwer and Spain's General Council of Economists aims to tackle the digital skills gap and redefine the profession.

An innovator in single-molecule imaging is teaming up with a multiplex giant. This collaboration could redefine diagnostic sensitivity and market dynamics.

As AI's energy demand soars, a new generation of cooling technology is crucial. Schneider Electric's latest innovation aims to make AI sustainable.

A Seoul-based AI firm, backed by giants, is set to tackle Southeast Asia's multilingual complexity. This is the story of how AI is becoming the new lingua franca for trade.

A new AI model from ZeroToOne.AI and GroundTruth predicts consumer behavior with startling accuracy, promising to end wasted ad spend and reshape marketing.

With fraud shifting across the customer journey, a new AI platform promises to approve more good customers by analyzing risk from account creation to post-purchase.

As AI-powered crime surges, DataVisor appoints scaling expert Patrick Harr to lead the charge, betting on AI-native defense to win the war on fraud.

Therini Bio's novel drug THN391 enters trials, targeting inflammation in diabetic eye disease, while a next-gen combo therapy aims to redefine care.

With backing from GV and Dexcom, Signos is using AI and OTC glucose monitors to offer a new path for sustainable weight management beyond GLP-1 drugs.

Sensorium Therapeutics advances SNTX-2643, a novel anxiety drug, while adding a new CMO and an expert advisory board to guide its clinical journey.